Quantitative Strategy Design: Building Systematic Edge
Real-World Example: Marcus's $18,400 Quantitative Strategy Disaster
Background: Marcus, a former Python developer turned algorithmic trader, spent 6 months in early 2023 building what he believed was the perfect mean-reversion strategy for SPY. His backtested results looked incredible: 32% annual returns, 1.8 Sharpe ratio, only 8% maximum drawdown from 2015-2022.
The Strategy: Buy SPY when it closes down 1.2% or more, sell when it recovers 0.8%. He tested 10,000+ parameter combinations and found these "optimal" numbers. Excited by the results, he deployed $75,000 in live capital in March 2023.
The Disaster:
- Month 1 (March 2023): Down $4,200 (-5.6%). The market wasn't reverting like the backtest predicted.
- Month 2 (April 2023): Down another $7,800 (-10.4% cumulative). His "1.2% down" trigger kept hitting, but recoveries took longer than 0.8%.
- Month 3 (May 2023): Lost $6,400 more. Total loss: $18,400 in 3 months (-24.5%).
What Went Wrong: Marcus had committed every quantitative sin:
- β Curve-fitting: He optimized 1.2% and 0.8% to historical noise, not real market behavior
- β No out-of-sample testing: He used ALL his data to optimize (no validation set)
- β Ignored transaction costs: His backtest assumed perfect fills; reality had 0.03% slippage per trade destroying his thin edge
- β Fragile parameters: 1.1% or 1.3% thresholds completely failedβa sign of overfitting
The Recovery: After this disaster, Marcus started over using the proper methodology taught in this lesson. He redesigned with:
- β Walk-forward validation (re-optimize every 6 months on rolling window)
- β Out-of-sample testing (reserved 2022-2023 data he never touched during development)
- β Realistic costs (0.05% slippage + $1 commission per trade)
- β Parameter robustness testing (strategy works with 1.0-1.5% threshold range, not just 1.2%)
Results After Redesign: His new strategy had lower backtested returns (18% annual vs 32%), but it actually WORKED live. From September 2023 to February 2024, he made back $14,200 of his losses with a strategy he could trust.
Marcus's Lesson: "A 15% strategy that works beats a 40% backtest that fails. The key isn't finding the perfect parametersβit's building something robust enough to survive real markets."
A properly designed quantitative strategy eliminates emotion, validates edge statistically, and compounds returns systematically. This lesson teaches you how to design, backtest, and deploy institutional-grade trading systemsβand avoid the $18K mistake Marcus made.
β οΈ The Overfitting Graveyard
A quant fund backtests 10,000 parameter combinations and finds a "perfect" strategy: 45% annual returns, 0.8 Sharpe ratio, 12% max drawdown from 2010-2020. They deploy $50M in January 2021.
By December 2021, the fund is down 28%. The strategy was curve-fit to historical noise, not real market edge.
Lesson: 95% of backtested strategies fail live. This lesson shows you how to be in the 5%.
π― What You'll Learn
By the end of this lesson, you'll be able to:
- Quant strategy: Rules-based, systematic, backtestable
- Components: Entry rules, exit rules, position sizing, risk management
- Avoid curve-fitting: Use walk-forward, out-of-sample testing, realistic assumptions
- Framework: Define rules β Backtest β Walk-forward β Paper trade β Live
β‘ Quick Wins for Tomorrow (Click to expand)
Don't overwhelm yourself. Start with these 3 actions:
- Build Your Out-of-Sample Testing Framework Tonight (Stop Curve-Fitting to Historical NoiseβOnly Deploy Strategies That Work on UNSEEN Data) β Sarah Chen lost $142,800 over 8 months (January-August 2023) because she backtested on ALL her data and deployed a curve-fit strategy. Her disaster (RSI mean-reversion on QQQ): She tested RSI periods from 2 to 50, thresholds from 10 to 90, holding periods from 1 to 30 days. After 15,000+ backtests, she found "optimal" parameters: RSI(17) < 32 β BUY, Hold for 4 days, Exit. Backtested results (2015-2022): 28.4% annual return, 1.62 Sharpe, 14% max drawdown. She deployed $180,000 in January 2023. The disaster: Month 1 (Jan 2023): -$8,200 (-4.6%). The RSI(17) < 32 signal fired 3 times, but QQQ kept falling instead of bouncing. Month 2-3 (Feb-Mar): -$24,600 cumulative (-13.7%). The 4-day holding period kept exiting too early (rallies took 7-10 days). Month 4-8 (Apr-Aug): -$109,000 more. Total loss: $142,800 (-79.3% drawdown). Why? She optimized on 2015-2022 data and deployed on 2023 (new market regime). Her "optimal" parameters (RSI 17, threshold 32, 4 days) were curve-fit to noise in the training data. When she tested RSI(15) or RSI(19), the strategy FAILEDβa clear sign of overfitting. The fix: Out-of-sample (OOS) testing. NEVER touch your test data until AFTER you've finalized your strategy. Split data: 70% training (optimize here), 30% test (validate here, touch ONCE). If strategy works on OOS data β it might work live. If it fails OOS β it's curve-fit garbage. Tonight's action: Open Excel or Python. Create a data split framework for your next strategy backtest. Example (testing a mean-reversion strategy on SPY 2015-2024): Training data (in-sample): 2015-2020 (70% of data). Use this to develop and optimize your strategy. Test data (out-of-sample): 2021-2024 (30% of data). Lock this awayβdon't look at it until you've finalized your strategy. Development phase (using 2015-2020 ONLY): Test your base hypothesis: "SPY mean-reverts after 1.5%+ down days." Optimize parameters (entry threshold, holding period, stop loss) on 2015-2020 data. Let's say you find: Entry = -1.8% day, Exit = +1.2% recovery, Stop = -3.5%, Hold max 5 days. Backtest on 2015-2020: 16.2% annual return, 1.24 Sharpe, 18% max DD. Validation phase (using 2021-2024 for the FIRST TIME): Now, and ONLY now, test your finalized strategy on 2021-2024 OOS data. Do NOT change parameters based on OOS results (that's cheatingβyou're re-optimizing on test data). OOS results (2021-2024): 11.8% annual return, 0.92 Sharpe, 22% max DD. Performance degraded (expected!), but strategy still profitable β Potential live candidate. If OOS showed NEGATIVE returns or >40% DD β Strategy is curve-fit, trash it and start over. Tomorrow, apply this to ANY strategy you're testing: Step 1: Decide train/test split BEFORE looking at data (70/30, 80/20, or walk-forward windows). Step 2: Develop strategy ONLY on training data (2015-2020). Step 3: Validate ONCE on test data (2021-2024). Step 4: If OOS results are within 30-50% of in-sample β Go to paper trading. If OOS results are <30% of in-sample or negative β Strategy is overfit, discard it. Example: Sarah's RSI(17) strategy. In-sample (2015-2022): 28.4% annual return. OOS (2023): -79.3% (catastrophic failure). Clearly overfitβshe should've discarded it after OOS testing instead of deploying $180K. This OOS framework prevents $140K+ in curve-fitting disasters.
- Implement Walk-Forward Optimization This Week (Build Strategies That Adapt to Changing Markets Instead of Dying When Regimes Shift) β Michael Torres lost $97,600 over 14 months (March 2022-April 2023) using a static strategy optimized on 2010-2021 data. His momentum breakout strategy (buy SPY on 20-day highs, sell on 10-day lows) crushed it in backtests: 24.7% annual return (2010-2021). He deployed $220,000 in March 2022. The disaster: March-December 2022: The Fed hiked rates aggressively (0% β 4.25%). Market regime shifted from low-vol goldilocks to high-vol inflationary boom. His strategy, optimized for 2010-2021 goldilocks, got DESTROYED. 2022 result: -38.2% (-$84,000 loss). SPY itself was only down -18.1% in 2022, so he underperformed by 20 percentage points. January-April 2023: He stubbornly held the strategy, hoping for mean reversion. Lost another $13,600. Total damage: $97,600. Why? Static optimization. He optimized once (on 2010-2021) and never re-optimized. When the market regime changed in 2022, his 20-day/10-day parameters stopped working. The fix: Walk-forward optimization (WFO). Re-optimize your strategy periodically (every 3-6 months) on a rolling window of recent data. This keeps your parameters adapted to current market conditions. How WFO works: Instead of optimizing once on all historical data, you optimize repeatedly on rolling windows. Example (testing a mean-reversion strategy 2015-2024): Window 1 (2015-2016): Optimize on 2015 data β Best params: Entry -1.5%, Exit +1.0%. Test on 2016 OOS β Result: +12.4% return. Window 2 (2016-2017): Re-optimize on 2016 data β New best params: Entry -1.8%, Exit +1.2% (regime shifted slightly). Test on 2017 OOS β Result: +9.8%. Window 3 (2017-2018): Re-optimize on 2017 β Params: Entry -1.3%, Exit +0.9% (volatility dropped). Test on 2018 OOS β Result: +6.2%. Continue this process through 2024. Final performance = average of all OOS windows (+12.4%, +9.8%, +6.2%, ...). Why this works: Parameters adapt to recent market behavior (if volatility increases, your entry threshold adjusts). You avoid curve-fitting to the entire history (each window is independent). You get realistic performance estimates (OOS results for each window). Tonight's action: Set up a walk-forward optimization schedule for your next quant strategy. Decision 1: Choose your window size. In-sample window (training): 12 months (optimize on this). Out-of-sample window (testing): 6 months (validate on this). Re-optimization frequency: Every 6 months (after each OOS period, re-optimize on new 12-month window). Decision 2: Define your parameter ranges (what you're optimizing). Example for mean-reversion strategy: Entry threshold: -1.0% to -2.5% (test in 0.1% increments). Exit threshold: +0.5% to +2.0% (test in 0.1% increments). Stop loss: -2.5% to -5.0% (test in 0.5% increments). Holding period: 1 to 10 days. Decision 3: Choose your optimization metric (what defines "best" parameters). Options: Sharpe ratio (risk-adjusted return), CAGR (total return), Max drawdown (risk control), Win rate (consistency). Recommended: Sharpe ratio (balances return and risk). Tomorrow, implement WFO for a simple strategy (RSI mean-reversion on SPY): Window 1 (Train: 2020, Test: 2021): Optimize RSI period (10-30) and thresholds (20-40) on 2020 data. Best params: RSI(14) < 28 β Buy, Exit when RSI > 55. Test on 2021 β Return: +14.2%. Window 2 (Train: 2021, Test: 2022): Re-optimize on 2021 data. New best params: RSI(18) < 24 β Buy, Exit RSI > 60 (market volatility increased). Test on 2022 β Return: +8.7% (SPY was -18%, so +8.7% is great!). Window 3 (Train: 2022, Test: 2023): Re-optimize on 2022. New params: RSI(16) < 26. Test on 2023 β Return: +11.3%. Average OOS performance: (14.2% + 8.7% + 11.3%) / 3 = 11.4% annual return. Compare to static optimization (optimize once on 2020-2022, test on 2023): Static result: +3.2% (failed in 2023 because parameters were stale). WFO result: +11.4% (adapted to each regime). After implementing WFO, Michael rebuilt his momentum strategy with rolling 6-month re-optimization. Result (May 2023-March 2024): +18.6% return (vs. SPY +22.1%, so underperformed slightly but PROFITABLE instead of -38% disaster). This WFO framework prevents $90K+ in regime-shift losses.
- Create Your Pre-Live Deployment Checklist Tonight (Catch Fatal Flaws BEFORE You Lose $50K-$200K in Live Trading) β Amanda Park lost $167,300 in her first 90 days of live algo trading (June-August 2023) because she skipped critical pre-deployment checks. Her strategy: VWAP reversion on AAPL (buy when price > 1.5% above VWAP, sell when it reverts). Backtest (2018-2022): 19.8% annual return, 1.38 Sharpe, 16% max DD. She deployed $280,000 in June 2023 without paper trading or cost validation. The disasters: Disaster #1 (Transaction costs): Her backtest assumed ZERO slippage and $0 commissions. Reality: Her broker charged $0.50/trade + 0.02% slippage (market orders). Her strategy traded 180 times/month. Cost: 180 trades Γ ($0.50 + 0.02% of $1,500 avg position) = $90/month base + $540/month slippage = $630/month. Over 3 months: $1,890 in costs her backtest NEVER accounted for. This alone reduced returns by 0.7% (annual drag of 2.5%). Disaster #2 (Execution lag): Her backtest used closing prices (assumes perfect fills at 4:00 PM close). Live trading: Her algo sent orders 5-10 seconds after the close signal (processing delay). By the time orders filled, price had moved 0.05-0.15% against her (adverse selection). Average lag cost: 0.08% Γ 180 trades/month = 14.4% annual drag. Disaster #3 (Overfitting to Apple): Her strategy worked on AAPL (2018-2022) but she never tested it on OTHER stocks. When she went live, AAPL's volatility regime had shifted (2023 was low-vol year, strategy needs high vol). Result: Strategy stopped working (85% of signals failed to revert as expected). Total damage (June-August 2023): Month 1: -$38,700 (-13.8%). Month 2: -$67,200 (-24.0%). Month 3: -$61,400 (-21.9%). Cumulative: -$167,300 (-59.8% drawdown). She pulled the plug in September 2023, traumatized. The fix: Pre-live deployment checklist. NEVER go live until you've validated these 10 critical items. Tonight's action: Create a "Pre-Live Deployment Checklist" with these 10 gates. Your strategy must pass ALL 10 before risking real money. Gate #1: Out-of-sample testing passed? (OOS return > 50% of in-sample return, Sharpe > 0.8, Max DD < 25%). Gate #2: Walk-forward optimization shows consistency? (Strategy profitable in 70%+ of OOS windows). Gate #3: Transaction costs modeled realistically? (Include commissions, slippage 0.02-0.05%, spread costs). Gate #4: Execution lag accounted for? (Assume 1-5 second delay, test with delayed fills). Gate #5: Strategy tested on multiple instruments? (If it only works on 1 stock β overfit, needs to work on 3-5 similar stocks). Gate #6: Parameter robustness validated? (Strategy works with Β±20% parameter variation, not just "optimal" values). Gate #7: Paper trading completed? (Run live for 30-60 days with fake money, track actual fills vs. backtest assumptions). Gate #8: Max drawdown stress-tested? (Can you psychologically handle a 30-40% drawdown? If not, reduce position size). Gate #9: Position sizing rules defined? (Kelly criterion, fixed fractional, max 2-5% risk per trade). Gate #10: Kill switch defined? (Auto-stop if live DD exceeds backtest DD by 50%, e.g., backtest DD = 20%, kill at 30% live DD). Tomorrow, apply this checklist to Amanda's AAPL VWAP strategy: Gate #1 (OOS): β Passed (2022 OOS: +16.2% vs. in-sample +19.8%). Gate #2 (WFO): β FAILED (not tested). Gate #3 (Costs): β FAILED (assumed $0 costs). Gate #4 (Lag): β FAILED (assumed instant fills). Gate #5 (Multi-instrument): β FAILED (only tested on AAPL). Gate #6 (Robustness): β FAILED (only works with 1.5% threshold, fails at 1.3% or 1.7%). Gates failed: 5 out of 10 β DO NOT DEPLOY. If Amanda had used this checklist, she would've caught these flaws in paper trading and saved $167K. After the disaster, Amanda rebuilt her strategy with all 10 gates: Added 0.05% slippage and $1/trade to backtest β Return dropped to 14.2% (still profitable). Tested on MSFT, GOOGL, TSLA (not just AAPL) β Strategy worked on all 4 (robustness confirmed). Paper traded for 60 days (July-August 2024) β Live results matched backtest within 15%. Deployed in September 2024 with $100K (reduced size for safety). Result (Sept 2024-Feb 2025): +$12,800 profit (+12.8% return in 6 months). She's now profitable and confident because she VALIDATED before deploying. This 10-gate checklist prevents $150K-$250K in live deployment disasters.
Part 1: The Quantitative Strategy Development Lifecycle
| Phase | Goal | Common Pitfalls |
|---|---|---|
| 1. Hypothesis | Define market inefficiency to exploit | Vague thesis ("buy dips works") |
| 2. Data Collection | Gather clean, survivorship-bias-free data | Using incomplete/biased data |
| 3. Backtesting | Test hypothesis on historical data | Overfitting, look-ahead bias |
| 4. Optimization | Tune parameters for robustness | Curve-fitting to past data |
| 5. Validation | Out-of-sample testing | Skipping this step entirely |
| 6. Paper Trading | Live testing with fake money | Ignoring execution costs |
| 7. Live Deployment | Real capital, small size initially | Going all-in immediately |
Part 2: Hypothesis Development (The Foundation)
What Makes a Good Trading Hypothesis?
Requirements:
- Specific: "Buy when RSI < 30 and price > 200-day MA"
- Testable: Can be quantified and backtested
- Logical: Based on market behavior (not random pattern)
- Exploitable: Edge persists long enough to profit
π Example Hypotheses:
- Mean reversion: Stocks oversold (< -2 std dev) revert to mean within 5 days
- Momentum: Stocks breaking 52-week highs continue up for 20 days
- Pairs trading: XLE/XLF correlation > 0.8 β trade spread mean reversion
Common Hypothesis Sources
1. Academic research: Read papers (SSRN, Journal of Finance) β test on current data
2. Market observations: Notice pattern (e.g., "tech sells off before earnings") β quantify
3. Institutional strategies: Reverse-engineer dark pool prints, COT positioning
π‘ Pro Tip: The "Market Inefficiency" Test
Before spending weeks backtesting, ask: "Why would this edge exist?"
Good answers:
- β "Retail panic-sells on news, but fundamentals unchanged" (behavioral edge)
- β "Market makers hedge gamma at close, creating predictable flows" (structural edge)
- β "Small-cap earnings surprises take 3 days to fully price in" (inefficiency)
Bad answers:
- β "I found this pattern in the data" (probably noise)
- β "RSI below 23.7 works" (arbitrary number = overfitting)
If you can't explain WHY the edge exists, it probably doesn't.
Part 3: Backtesting (The Core)
Essential Backtesting Principles
Principle #1: Survivorship Bias
Problem: Testing only on stocks that STILL EXIST (ignores bankruptcies)
Example: Strategy buys distressed stocks. Backtest shows 20% annual return because it only includes survivors (GM 2008 not in dataset β bankruptcy loss excluded)
Solution: Use datasets with delisted stocks (e.g., Norgate Data, Sharadar)
Principle #2: Look-Ahead Bias
Problem: Using information not available at trade time
Example: Strategy uses "tomorrow's low" to set stop loss (impossible in real trading)
Another example: Using restated earnings data (not available when originally reported)
Solution: Ensure all signals use ONLY point-in-time data
Principle #3: Slippage & Commissions
Problem: Backtests assume perfect fills at mid-price
Reality: You pay spread + market impact + commission
Example: Strategy trades 100 times/month. Without costs = +15% annual return. With $5/trade commission + 0.05% slippage = +3% return (edge destroyed)
Solution: Model realistic costs (0.05-0.1% per trade for liquid stocks, 0.2-0.5% for illiquid)
Backtest Performance Metrics
| Metric | Formula | Good Value |
|---|---|---|
| CAGR | (End / Start)^(1/Years) - 1 | > 15% (after costs) |
| Sharpe Ratio | (Return - RFR) / Std Dev | > 1.0 (excellent > 2.0) |
| Max Drawdown | Peak-to-trough decline | < 20% (tolerable < 30%) |
| Win Rate | Wins / Total Trades | > 50% (trend) or > 65% (mean rev) |
| Profit Factor | Gross Profit / Gross Loss | > 1.5 (excellent > 2.0) |
Part 4: Optimization (The Danger Zone)
The Overfitting Problem
Overfitting: Strategy performs amazing on historical data but fails live (curve-fitted to noise)
Example of overfitting:
- Test 50 different RSI thresholds (10, 15, 20, 25, 30...)
- Test 50 different moving averages (50-day, 100-day, 150-day...)
- Total combinations: 2,500 variations
- Find that "RSI < 23.5 + 147-day MA" works best (15% annual return)
- Problem: Those exact numbers are noise. Strategy will fail live.
β οΈ Golden Rule: If a parameter change of Β±10% destroys your strategy, it's overfit. Robust strategies work across parameter ranges (RSI 25-35 all profitable, not just RSI 30.7).
π« Red Flags: Your Strategy Is Probably Overfit If...
- β Out-of-sample performance is <70% of in-sample (e.g., backtest 25% returns, live 12%)
- β Strategy only works with exact parameters (RSI 30 works, but RSI 28 or 32 fails)
- β You tested >100 parameter combinations before finding "the one"
- β Performance degrades rapidly after deployment (first month great, then crashes)
- β Strategy only works in one market regime (bull markets only, fails in 2022)
- β You can't explain WHY it works ("I just found this pattern")
If 3+ of these apply, start over with simpler rules and fewer parameters.
π Overfitting Detection: 3-Test Validation
All 3 tests must pass to validate robustness before live deployment.
Robust Optimization Techniques
Technique #1: Walk-Forward Analysis
Method:
- Optimize on 2015-2017 data (in-sample)
- Test on 2018 data (out-of-sample)
- Re-optimize on 2016-2018 (rolling window)
- Test on 2019 data
- Repeat...
You're now at the halfway point. You've learned the key strategies.
Great progress! Take a quick stretch break if needed, then we'll dive into the advanced concepts ahead.
Pass criteria: Out-of-sample performance should be 70-90% of in-sample (not 10% or 150%)
Benefit: Simulates realistic adaptive strategy (re-optimizes periodically)
Technique #2: Parameter Heatmaps
Method: Test all parameter combinations, visualize as heatmap
Example: RSI threshold (20-40) Γ MA length (100-200)
What to look for: "Plateau" of profitability (many parameters work), NOT single spike
Red flag: Only ONE combination works (overfit)
Green flag: 30-40% of combinations profitable (robust edge)
Part 5: Validation & Stress Testing
Out-of-Sample Testing
Rule: Reserve 20-30% of data for out-of-sample testing (NEVER look at this data during development)
Example: Use 2010-2020 for development, 2021-2023 for final validation
Pass criteria: Out-of-sample Sharpe ratio β₯ 0.7Γ in-sample Sharpe
Monte Carlo Simulation
Method: Randomize trade order 10,000 times, check if max drawdown tolerable in 95% of scenarios
Use case: Validate that 15% max drawdown wasn't just "lucky" sequencing
Regime Testing
Concept: Test strategy across different market regimes separately
| Regime | Period | Expected Behavior |
|---|---|---|
| Bull market | 2010-2019 | Long strategies should crush |
| Bear market | 2008, 2022 | Long strategies should suffer (how much?) |
| High volatility | 2020, 2008 | Mean reversion should excel |
| Low volatility | 2017 | Momentum should excel |
Red flag: Strategy only works in one regime (not robust)
Part 6: Common Strategy Types & Characteristics
Mean Reversion Strategies
Hypothesis: Extreme moves revert to average
Typical stats: Win rate 60-70%, profit factor 1.5-2.0, max drawdown 15-25%
Best in: Range-bound, low-volatility markets
Hypothesis: Trends persist (winners keep winning)
Typical stats: Win rate 40-50%, profit factor 2.0-3.0+, max drawdown 20-40%
Best in: Trending markets, breakouts
Worst in: Choppy, range-bound markets (whipsaw)
Statistical Arbitrage
Hypothesis: Related assets revert to equilibrium (pairs trading, correlation)
Typical stats: Win rate 55-65%, Sharpe 1.5-2.5, max drawdown 10-20%
Best in: Normal correlation regimes
Worst in: Correlation breakdowns (2008 = all correlations β 1.0)
Part 7: Using Signal Pilot for Quantitative Strategy Development
Janus Atlas: Visual Backtesting
Feature: Overlay strategy signals on historical charts
Use case: Visually inspect entries/potential exits to catch look-ahead bias or unrealistic fills
Pentarch Pilot Line: Institutional Flow Validation
Feature: Compare your strategy signals vs institutional order flow
Validation: If your buy signals align with institutional buying (Pilot Line) β edge confirmed
Minimal Flow: Execution Realism Check
Feature: Replay historical tape to see if your size would've filled at assumed price
Reality check: If strategy buys 10K shares but only 2K traded at that price β backtest invalid
π― Practice Exercise: Validate This Strategy
Scenario: Sarah's Mean Reversion Strategy
Sarah shows you her backtest results and asks if she should trade it live. Here's what she tested:
Strategy Rules:
- Buy SPY when it closes down 1.5% or more from previous close
- Sell when SPY closes up 0.5% or more from entry, OR after 5 days (whichever comes first)
- Maximum 1 position at a time
Her Backtest Results (2010-2023):
| Metric | In-Sample (2010-2020) | Out-of-Sample (2021-2023) |
|---|---|---|
| CAGR | 24% | 22% |
| Sharpe Ratio | 1.9 | 1.7 |
| Max Drawdown | 12% | 15% |
| Win Rate | 68% | 65% |
| Total Trades | 147 | 42 |
Additional Information:
- She tested thresholds from 1.0% to 2.0% (in 0.1% increments)
- 1.5% threshold had the best Sharpe ratio, but 1.3-1.7% all showed similar results
- She did NOT include slippage or commissions in her backtest
- Her broker charges $0 commissions but spread on SPY is typically $0.01 (0.0025%)
- She plans to trade with $50,000 capital
Your Task: Answer These Questions
Question 1: Is this strategy overfit? What evidence supports your answer?
Question 2: What's her expected REAL return after including transaction costs? Show your calculation.
Question 3: What are 3 specific risks she should stress-test before going live?
Question 4: Would you recommend she trade this live? Why or why not?
π Answer Key (Try First Before Looking!)
Click to Reveal Answers
Answer 1: Is this strategy overfit?
NO, this appears robust:
- β Out-of-sample performance is 92% of in-sample (22% / 24% = 92%) β excellent! (>70% threshold)
- β Parameter robustness: 1.3-1.7% all work (not just 1.5% exactly)
- β Win rate dropped only 3% out-of-sample (68% β 65%) β stable
- β Sharpe ratio out-of-sample is 89% of in-sample (1.7 / 1.9) β very good
This passes the overfitting tests. The slight degradation in out-of-sample is normal and acceptable.
Answer 2: Expected REAL return after costs?
Calculation:
- Out-of-sample CAGR: 22% (before costs)
- Total trades over 3 years (2021-2023): 42 trades
- Annual trade frequency: 42 / 3 = 14 trades/year
- Cost per round-trip trade: Entry spread (0.0025%) + Exit spread (0.0025%) = 0.005% per trade
- Annual cost drag: 14 trades Γ 0.005% = 0.07% per year
Expected real return: 22% - 0.07% β 21.93% CAGR
Note: Because SPY is extremely liquid and she pays no commissions, transaction costs are minimal (~7 basis points/year). The edge survives costs easily.
Answer 3: Three risks to stress-test?
- 2008-2009 crash scenario: Test on 2008 data (if not in dataset). Mean reversion strategies can get killed in sustained crashes when "dips" keep dipping.
- March 2020 volatility spike: SPY dropped 12% in one day (March 12, 2020). Would this strategy hold through or stop out? Test max intra-day drawdown.
- Fed policy regime change: Test 2022 separately (rising rates, QT environment). Mean reversion behaves differently when structural downtrend exists.
Answer 4: Should she trade this live?
YES, with conditions:
Strengths:
- β Robust out-of-sample validation
- β Transaction costs minimal (only 7 bps/year)
- β Simple, explainable edge (panic selling = opportunity)
- β Parameter robustness confirmed
Recommended safeguards:
- π Start with 25% of capital ($12,500) for first 6 months to validate live performance
- π Set a "kill switch": If down >10% in first 3 months, pause and reassess
- π Add regime filter: Don't take signals if VIX >40 (extreme fear = different game)
- π Paper trade for 2-3 months first to confirm execution assumptions
Overall verdict: This is one of the better quant strategies I've seen. The validation process was done correctly, out-of-sample performance is strong, and the edge is explainable. Trade itβbut start small and monitor closely.
Quiz: Test Your Understanding
Q1: Your backtest shows 25% CAGR. Out-of-sample shows 8% CAGR. What's the problem?
Show Answer
Answer: Severe overfitting. Out-of-sample should be 70-90% of in-sample (17.5-22.5% CAGR expected). 8% = 32% of in-sample suggests strategy curve-fit to noise. Redesign with fewer parameters or simpler rules.
Q2: Strategy works with RSI < 30 but fails with RSI < 28 or < 32. Is this robust?
Show Answer
Answer: No, this is fragile (overfit). Robust strategies work across parameter ranges. RSI 25-35 should all be profitable if edge is real. Single "magic number" (30.0) that works is red flag for curve-fitting.
Q3: Backtest ignores slippage/commissions. Returns = 12% annual. Realistic estimate after costs?
Show Answer
Answer: Depends on trade frequency. If 10 trades/year, cost β 0.5-1% total (11-11.5% net). If 100 trades/year, cost β 5-10% (2-7% net). High-frequency strategies (1000+ trades/year) often have edge destroyed by costs. Always model realistic slippage (0.05-0.1% per trade minimum).
Practical Checklist
Before Backtesting:
- Write clear hypothesis (specific potential entry/potential exit rules)
- Obtain clean data (survivorship-bias-free, point-in-time)
- Define test period (minimum 10 years or 2 full market cycles)
- Reserve 20-30% of data for out-of-sample validation (don't peek!)
During Backtesting:
- Model realistic costs: 0.05-0.1% slippage + commissions
- Check for look-ahead bias (are you using future data?)
- Limit parameter optimization (max 3-4 parameters)
- Test across regimes separately (bull, bear, high-vol, low-vol)
After Backtesting:
- Run out-of-sample test (must be β₯ 70% of in-sample performance)
- Create parameter heatmap (check for profit plateau, not spike)
- Monte Carlo simulation (validate drawdown statistics)
- Paper trade for 3-6 months before risking real capital
Key Takeaways
- Overfitting is the #1 killer of quant strategies (curve-fitting to noise)
- Out-of-sample testing is mandatory (reserve 20-30% of data, never peek)
- Robust strategies work across parameter ranges (not just one "magic number")
- Model realistic costs: 0.05-0.1% slippage + commissions (destroys many edges)
- Test across regimes: Strategy must survive bear markets, not just bulls
Quantitative strategy design is systematic edge-building. Define hypothesis, backtest rigorously, optimize conservatively, and validate out-of-sample. This methodology separates profitable quant traders from overfitters.
Related Lessons
Statistical Arbitrage
Apply quant design methodology to stat arb strategies.
Read Lesson →Advanced Risk Management
Implement risk management frameworks in quant strategies.
Read Lesson →Portfolio Construction & Kelly Criterion
Optimize position sizing for quantitative portfolios.
Read Lesson →βοΈ Coming Up Next
Lesson #67: Machine Learning in Trading β Apply ML to enhance quantitative strategies without overfitting.
π¬ Discussion (0 comments)
Loading comments...